Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.
about
Ubinuclein, a novel nuclear protein interacting with cellular and viral transcription factorsThe PKC targeting protein RACK1 interacts with the Epstein-Barr virus activator protein BZLF1TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 proteinEpstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodiesRegulation of apoptosis by viral gene productsEBNA2 and activated Notch induce expression of BATFViruses as co-factors for the initiation or exacerbation of lung fibrosisStructure of HAP1-PC7 bound to DNA: implications for DNA recognition and allosteric effects of DNA-binding on transcriptional activationMutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphomaThe B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex.Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter.Functional antagonism between the retinoic acid receptor and the viral transactivator BZLF1 is mediated by protein-protein interactions.Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation.The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins.Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylationUpregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator ZtaThe K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity.The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction.The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein.Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, ZtaSumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.Herpesvirus lytic replication and the cell cycle: arresting new developmentsControl of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1.Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification.Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1.Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax proteinEpstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol)The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanismsModeling early Epstein-Barr virus infection in Drosophila melanogaster: the BZLF1 proteinHuman papillomavirus detection in moroccan patients with nasopharyngeal carcinoma.Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha.Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis, and apoptosis-related proteins in gastric carcinoma.Phosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta.Analysis of an ankyrin-like region in Epstein Barr Virus encoded (EBV) BZLF-1 (ZEBRA) protein: implications for interactions with NF-κB and p53.p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease.Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivationThe Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter.YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter.
P2860
Q22253362-505FE8EE-82FF-4D31-8B9A-A54A80DCC58CQ22254235-720F7BF9-787B-4C32-8D8D-5DFF352528C2Q24320081-6C00A6D5-A28F-4BB1-99A3-3995F6457122Q24529499-2A22EDBE-6450-41D5-B0F3-A6A916414381Q24678703-6771D897-6196-4803-9032-4678A448D9CFQ24679432-25B6B52F-DE45-4773-931F-95B66CDA394FQ27487313-B7AB883F-9999-47CB-8264-E4EB2F213A3CQ27627395-3B22B83C-4E02-4C2C-BA7D-F180D15FFFC7Q28472086-27E8BFB5-A79F-4F2F-A798-018E8A39A8B0Q28480586-7F05706A-5F3B-4919-B5BA-65B9707342C4Q33489621-4CACA562-9AE1-49F4-B90C-E24E44E6C8C9Q33641552-C835B48E-11A5-4EF9-8853-621E2564EAFFQ33662787-7B668703-394F-4ABD-A32A-A51E50BBE0EAQ33784820-2DBAC1E7-DA00-4F03-A81D-731D07C75A5AQ33785198-B189CA63-0633-44DE-A4AF-367159DC7542Q33786869-9F672369-3021-475A-86D3-38C9A542527AQ33809585-32A766CC-C1BD-4F91-9248-77117A632664Q33813261-2AF62FC5-F528-48B8-917D-DF62F4DF002FQ33817088-5F101890-CF64-4B7F-BE21-F3C32125BCE4Q33817111-A02D2386-1E23-4F41-ADDE-38960CA5D113Q33822549-100A2DB6-50B8-42AA-8C17-E71286DC3E40Q33826641-4EF5BCC4-FF47-4549-93A7-0998206019ECQ33840180-100377FA-15DF-4555-B674-069FB21DD514Q33898010-4D441A9B-379F-4620-9CA8-E65E8985D540Q33908645-C8028DC2-FA7C-42C9-89EE-DAE39EB22FC4Q33908810-4CC1DD0E-2CC2-48C3-90A6-534319A30BDAQ33910725-5F80960A-244C-42C5-997F-D645D48E78A9Q34069424-503798AE-8AC7-476C-8702-17B084F0DA6AQ34301695-95714067-08CB-417A-B13C-59DE1C892496Q34350684-35469D66-EB8C-4EEE-8E55-AC59BCD5628FQ34589844-B06FE52A-1C98-4DD4-B438-1D249407598DQ34698907-BD8585EA-0899-4C52-92CB-25F1719503A6Q34751026-8DF821D7-1D47-409E-9A06-E2AAF50EEE30Q35045601-9B7068A1-E56C-4886-9940-6170DB4F3EBBQ35122852-078A449B-6068-4BEB-8760-FA4004D63E7EQ35233147-BA121BC9-D425-486E-A571-D3BF17FDFC06Q35747125-71A80956-4AB4-4AB0-91FA-D62851AA5309Q35835238-CD19D6B8-3C0D-408B-93B8-9E6B72B2E2D9Q35839977-D3E1340B-B92A-4CD9-8FD3-D2B20FDB6DF9Q35841116-7836B5A8-8FDB-408D-95FD-2003B5B96788
P2860
Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Functional and physical intera ...... or Epstein-Barr virus latency.
@ast
Functional and physical intera ...... or Epstein-Barr virus latency.
@en
type
label
Functional and physical intera ...... or Epstein-Barr virus latency.
@ast
Functional and physical intera ...... or Epstein-Barr virus latency.
@en
prefLabel
Functional and physical intera ...... or Epstein-Barr virus latency.
@ast
Functional and physical intera ...... or Epstein-Barr virus latency.
@en
P2093
P2860
P356
P1476
Functional and physical intera ...... or Epstein-Barr virus latency.
@en
P2093
P2860
P304
P356
10.1128/MCB.14.3.1929
P407
P577
1994-03-01T00:00:00Z